For nearly 25 years, GlaxoSmithKline’s (“GSK”) Zofran (ondansetron) has been used to alleviate nausea and vomiting in cancer patients enduring chemotherapy or radiation therapy—however the FDA has never approved the anti-nausea medicine for use in pregnant women. Unfortunately, GSK’s alleged “off label” marketing of the drug to expectant mothers may have cost one family...
Ohio Couple Blames Zofran (ondansetron) for Daughter’s Death
Read more
